Figure 7From: Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson’s disease patients Quantification of Iba1 immunoreactivity (IR) in the substantia nigra (SN) and hippocampal CA2 region of control subjects, iLBD cases and PD patients. (a) A significant increase was present in Iba1 IR in the SN of PD patients relative to control subjects (*p < 0.05 vs Ctr); (b) no significant difference was present in the CA2. Data represent mean ± SEM.Back to article page